Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Binder TMC"'
Autor:
Nikolaos A. Patsopoulos, Gil McVean, Juliane Winkelmann, F. Martinelli-Boneschi, An Goris, A Compston, Gourraud P-A., Hanne F. Harbo, Calliope A. Dendrou, Annette Bang Oturai, Elisabeth Gulowsen Celius, Dionysia Kiara Xifara, Sandra D'Alfonso, B. Hemmer, Lars Fugger, Helle Bach Søndergaard, Peter Donnelly, Luke Jostins, Sergio E. Baranzini, Frauke Zipp, Binder Tmc., Tomas Olsson, Lars Alfredsson, Ashley Beecham, Carl A. Anderson, Bénédicte Dubois, David A. Hafler, Janna Saarela, Maria Ban, Jorge R. Oksenberg, Ingrid Kockum, Margaret A. Pericak-Vance, Jan Hillert, Jacob L. McCauley, Stephen Sawcer, Kathrine E. Attfield, Bertrand Fontaine, Chris Cotsapas, Christiane Graetz, P. L. De Jager, Christina M. Lill, Bruce V. Taylor, Stephen Leslie, Jonathan L. Haines, Dorothea Buck, Stephen L. Hauser, Anne Spurkland, Jeffrey C. Barrett, Tejas Shah, Spencer Cca., David R. Booth, Loukas Moutsianas, Adrian J. Ivinson, Alexander T. Dilthey, Graeme J. Stewart
Association studies have greatly refined the understanding of how variation within the human leukocyte antigen (HLA) genes influences risk of multiple sclerosis. However, the extent to which major effects are modulated by interactions is poorly chara
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e383fdaa0fd14fba880840f06454b89
https://europepmc.org/articles/PMC4874245/
https://europepmc.org/articles/PMC4874245/
Autor:
Beecham, AH, Patsopoulos, NA, Xifara, DK, Davis, MF, Kemppinen, A, Cotsapas, C, Shah, TS, Spencer, C, Booth, D, Goris, A, Oturai, A, Saarela, J, Fontaine, B, Hemmer, B, Martin, C, Zipp, F, D'Alfonso, S, Martinelli-Boneschi, F, Taylor, B, Harbo, HF, Kockum, I, Hillert, J, Olsson, T, Ban, M, Oksenberg, JR, Hintzen, R, Barcellos, LF, Agliardi, C, Alfredsson, L, Alizadeh, M, Anderson, C, Andrews, R, Søndergaard, HB, Baker, A, Band, G, Baranzini, SE, Barizzone, N, Barrett, J, Bellenguez, C, Bergamaschi, L, Bernardinelli, L, Berthele, A, Biberacher, V, Binder, TMC, Blackburn, H, Bomfim, IL, Brambilla, P, Broadley, S, Brochet, B, Brundin, L, Buck, D, Butzkueven, H, Caillier, SJ, Camu, W, Carpentier, W, Cavalla, P, Celius, EG, Coman, I, Comi, G, Corrado, L, Cosemans, L, Cournu-Rebeix, I, Cree, BAC, Cusi, D, Damotte, V, Defer, G, Delgado, SR, Deloukas, P, Di Sapio, A, Dilthey, AT, Donnelly, P, Dubois, B, Duddy, M, Edkins, S, Elovaara, I, Esposito, F, Evangelou, N, Fiddes, B, Field, J, Franke, A
Publikováno v:
Beecham, AH; Patsopoulos, NA; Xifara, DK; Davis, MF; Kemppinen, A; Cotsapas, C; et al.(2013). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nature Genetics, 45(11), 1353-1362. doi: 10.1038/ng.2770. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/0tz6x2q0
Using the ImmunoChip custom genotyping array, we analyzed 14,498 subjects with multiple sclerosis and 24,091 healthy controls for 161,311 autosomal variants and identified 135 potentially associated regions (P < 1.0 × 10 -4). In a replication phase,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::3cbd226ce07622c6ab0f1afe7e90bad2
http://www.escholarship.org/uc/item/0tz6x2q0
http://www.escholarship.org/uc/item/0tz6x2q0
Autor:
Wang J; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Jelcic I; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Mühlenbruch L; Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen 72076, Germany., Haunerdinger V; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, Zurich 8032, Switzerland., Toussaint NC; NEXUS Personalized Health Technologies, ETH Zurich, Zurich 8093, Switzerland; Swiss Institute of Bioinformatics, Zurich, Switzerland., Zhao Y; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD 20850, USA., Cruciani C; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Faigle W; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Naghavian R; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Foege M; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Binder TMC; HLA Laboratory of the Stefan Morsch Foundation (SMS), Birkenfeld 55765, Germany., Eiermann T; Department of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany., Opitz L; Functional Genomics Center Zurich, Swiss Federal Institute of Technology and University of Zurich, Zurich 8057, Switzerland., Fuentes-Font L; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK., Reynolds R; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK., Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA., Nguyen JT; One Lambda, Inc., a part of Transplant Diagnostics Thermo Fisher Scientific, 22801 Roscoe Blvd., West Hills, CA 91304, USA., Lee JH; One Lambda, Inc., a part of Transplant Diagnostics Thermo Fisher Scientific, 22801 Roscoe Blvd., West Hills, CA 91304, USA., Lutterotti A; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Münz C; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland., Rammensee HG; Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen 72076, Germany., Hauri-Hohl M; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, Zurich 8032, Switzerland., Sospedra M; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland., Stevanovic S; Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies,' University of Tübingen, Tübingen 72076, Germany., Martin R; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland. Electronic address: roland.martin@usz.ch.
Publikováno v:
Cell [Cell] 2020 Nov 25; Vol. 183 (5), pp. 1264-1281.e20. Date of Electronic Publication: 2020 Oct 21.
Autor:
Enz LS; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Zeis T; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Schmid D; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Geier F; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., van der Meer F; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Steiner G; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Certa U; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Binder TMC; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Stadelmann C; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Martin R; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland., Schaeren-Wiemers N; From the Neurobiology (L.S.E., T.Z., D.S., N.S.-W.), Department of Biomedicine, University Hospital Basel, University Basel, Zentrum für Lehre und Forschung, Switzerland; Department of Biomedicine (F.G.), Bioinformatics Core Facility, University Hospital Basel, Switzerland; SIB Swiss Institute of Bioinformatics (F.G.), Basel, Switzerland; Institute of Neuropathology (F.v.d.M., C.S.), University Medical Center, Göttingen, Germany; Roche Pharma Research and Early Development (pRED) (G.S., U.C.), Roche Innovation Center Basel, Switzerland; Institute of Clinical Transfusion Medicine (T.M.C.B.), Hospital Braunschweig, Germany; and Neuroimmunology and MS Research (R.M.), Neurology Clinic, University Hospital Zurich, University Zurich, Switzerland. Nicole.schaeren-wiemers@unibas.ch.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2019 Dec 27; Vol. 7 (2). Date of Electronic Publication: 2019 Dec 27 (Print Publication: 2020).
Autor:
Moutsianas L; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Jostins L; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Beecham AH; John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA., Dilthey AT; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Xifara DK; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Ban M; Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Shah TS; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Patsopoulos NA; Program in Translational NeuroPsychiatric Genomics, Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Program in Medical and Population Genetics, Broad Institute of Harvard University and MIT, Cambridge, Massachusetts, USA., Alfredsson L; Institute of Environmental Medicine (IMM), Karolinska Institutet, Stockholm, Sweden., Anderson CA; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Attfield KE; Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Baranzini SE; Department of Neurology, University of California, San Francisco, Sandler Neurosciences Center, San Francisco, California, USA., Barrett J; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, UK., Binder TMC; HLA Laboratory, Department of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Booth D; Westmead Millennium Institute, University of Sydney, Sydney, New South Wales, Australia., Buck D; Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany., Celius EG; Department of Neurology, Oslo University Hospital, Ullevål, Oslo, Norway., Cotsapas C; Program in Medical and Population Genetics, Broad Institute of Harvard University and MIT, Cambridge, Massachusetts, USA.; Department of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, USA., D'Alfonso S; Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Department of Health Sciences, University of Eastern Piedmont, Novara, Italy., Dendrou CA; Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Donnelly P; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Dubois B; Department of Neurosciences, Laboratory for Neuroimmunology, KU Leuven, Leuven, Belgium., Fontaine B; INSERM, Université Pierre et Marie Curie, CNRS, Assistance Publique-Hôpitaux de Paris (AP-HP), Département des Maladies du Système Nerveux and UMRS 1127-7225, Institut Cerveau Moelle Spinal Cord and Brain Institute, Pitié-Salpêtrière, Paris, France., Fugger L; Medical Research Council (MRC) Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Nuffield Department of Clinical Neurosciences, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK., Goris A; Department of Neurosciences, Laboratory for Neuroimmunology, KU Leuven, Leuven, Belgium., Gourraud PA; Department of Neurology, University of California, San Francisco, Sandler Neurosciences Center, San Francisco, California, USA., Graetz C; Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), Johannes Gutenberg University-Medical Center, Mainz, Germany., Hemmer B; Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; German Competence Network Multiple Sclerosis (KKNMS), Munich, Germany., Hillert J; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Kockum I; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Leslie S; Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Melbourne, Victoria, Australia.; Department of Mathematics and Statistics, University of Melbourne, Parkville, Melbourne, Victoria, Australia., Lill CM; Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), Johannes Gutenberg University-Medical Center, Mainz, Germany.; Platform for Genome Analytics, Institutes of Neurogenetics and Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany., Martinelli-Boneschi F; Laboratory of Genetics of Neurological Complex Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.; Department of Neurology, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy., Oksenberg JR; Department of Neurology, University of California, San Francisco, Sandler Neurosciences Center, San Francisco, California, USA., Olsson T; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden., Oturai A; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital, Copenhagen, Denmark., Saarela J; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland., Søndergaard HB; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital, Copenhagen, Denmark., Spurkland A; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway., Taylor B; Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia., Winkelmann J; Department of Neurology, Klinikum Rechts der Isar, Technische Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.; Institut für Humangenetik, Technische Universität München, Munich, Germany.; Institut für Humangenetik, Helmholtz Zentrum München, Munich, Germany.; Department of Neurology and Neurological Sciences, Center for Sleep Sciences and Medicine, Stanford University, Stanford, California, USA., Zipp F; Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), Johannes Gutenberg University-Medical Center, Mainz, Germany., Haines JL; Center for Human Genetics Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Pericak-Vance MA; John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA., Spencer CCA; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK., Stewart G; Westmead Millennium Institute, University of Sydney, Sydney, New South Wales, Australia., Hafler DA; Program in Medical and Population Genetics, Broad Institute of Harvard University and MIT, Cambridge, Massachusetts, USA.; Department of Neurology and Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.; Broad Institute of Harvard University and MIT, Cambridge, Massachusetts, USA., Ivinson AJ; Harvard NeuroDiscovery Center, Harvard Medical School, Boston, Massachusetts, USA., Harbo HF; Department of Neurology, Oslo University Hospital, Ullevål, Oslo, Norway.; University of Oslo, Oslo, Norway., Hauser SL; Department of Neurology, University of California, San Francisco, Sandler Neurosciences Center, San Francisco, California, USA., De Jager PL; Program in Translational NeuroPsychiatric Genomics, Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Medicine, Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Program in Medical and Population Genetics, Broad Institute of Harvard University and MIT, Cambridge, Massachusetts, USA., Compston A; Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., McCauley JL; John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, Florida, USA., Sawcer S; Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., McVean G; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
Publikováno v:
Nature genetics [Nat Genet] 2015 Oct; Vol. 47 (10), pp. 1107-1113. Date of Electronic Publication: 2015 Sep 07.